登录 | 注册    关注公众号  
微信公众号
搜索
 >  Kits>PD-L1 >CAA-B001

PD-L1 IHC 5D3 Kit

For research use only.

背景(Background)

PD-L1 is an informative immunotherapy biomarker: Aberrant expression of PD-L1 on tumor and immune cells in the tumor microenvironment impedes anti-tumor immunity, allowing tumors to grow and metastasize. The PD-L1 IHC 5D3 Kit is a quick assay to detect PD-L1 across tumors to identify patients eligible for multiple targeted therapies. Kit product are manufactured in a dedicated GMP facility and are compliant with our ISO 13485 quality management system.

产品描述(Background)

Assay TypeImmunohistochemistry
AnalytePD-L1
Format2ml/7.5ml/30ml
ReactivityHuman
SpeciesRabbit
Regulatory StatusRUO
Applicable PlatformLEICA BOND III、DAKO link 48

组分(Materials Provided)

Recombinant Monoclonal Anti-PD-L1 Antibody, Rabbit (5D3)

Antibody diluent

应用说明(Application)

The kit is developed for use in the PD-L1 protein in the formalin-fixed, paraffin-embedded tissue. It is indicated as an aid in the assessment of PD-L1 expression in human tissues.

状态(State)

Liquid

存储(Storage)

Stored at 2°C to 8°C.

 

质控样本(Control Sample)

PD-L1 CONTROL SAMPLE

Use ACRO PD-L1 5D3 kit to stain human tonsil tissue, positive cell membrane specific positive staining (staining intensity ≥ 1), no non-specific staining (staining intensity < 1) , no background staining (staining intensity < 1).

肿瘤样本(Cancer Sample)

一致性(Consistency)

ACRO PD-L1 5D3 and DAKO PD-L1 22C3 conformance verification, with a high consistency rate (>95%).

PD-L1 CONSISTENCY

PD-L1 CONSISTENCY

PD-L1 CONSISTENCY

Use ACRO PD-L1 5D3 Kit and DAKO PD-L1 22C3 kit to stain non-small cell lung cancer, esophageal squamous cell carcinoma and liver cancer, respectively. The results showed that the staining effect was highly consistent.

扩展性(Extensibility)

ACRO PD-L1 5D3 kit expandable test: non-small cell lung cancer, esophageal carcinoma, gastric cancer, colorectal cancer and liver cancer.

PD-L1 EXTENSIBILITY

PD-L1 EXTENSIBILITY

PD-L1 EXTENSIBILITY

Use ACRO PD-L1 5D3 kit to stain NSCLC, esophageal carcinoma, gastric cancer, colorectal cancer, liver cancer tissue samples respectively.

适用性(Applicability)

ACRO PD-L1 5D3 can be available on the LEICA BOND III and DAKO Link 48 platform.

PD-L1 APPLICABILITY

PD-L1 APPLICABILITY

PD-L1 APPLICABILITY

Use ACRO PD-L1 5D3 kit to stain NSCLC tissue samples at Leica BOND-III and Dako link 48.

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
PD-L1靶点信息
英文全称:Programmed death-ligand 1
中文全称:程序性死亡配体1
种类:Homo sapiens
上市药物数量:7详情
临床药物数量:156详情
最高研发阶段:临床三期
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定